EV Biologics, Inc. (OTCMKTS:YECO – Get Free Report)’s stock price traded up 83.1% during mid-day trading on Tuesday . The company traded as high as $0.22 and last traded at $0.17. 780 shares were traded during trading, a decline of 76% from the average session volume of 3,277 shares. The stock had previously closed at $0.10.
EV Biologics Stock Performance
The stock’s 50-day moving average is $0.19 and its 200-day moving average is $0.24.
EV Biologics Company Profile
EV Biologics, Inc, a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces.
Further Reading
- Five stocks we like better than EV Biologics
- What is a Low P/E Ratio and What Does it Tell Investors?
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- What is the Euro STOXX 50 Index?
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Consumer Discretionary Stocks Explained
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for EV Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EV Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
